Vaccines
New Vaccines Study Results from A. Schneeberger et al Described
Published in Vaccine Weekly, February 22nd, 2012
2012 FEB 22 -- Data detailed in "Vaccination for Parkinson's disease" have been presented. According to the authors of recent research from Vienna, Austria, "Idiopathic Parkinson's disease (PD) is, like other neurodegenerative diseases such as Alzheimer's disease (AD) considered a proteinopathy. Thus, a disease that is driven by the accumulation and aggregation of misfolded proteins, in case of PD a-synuclein (aSyn) is incriminated."
"Accordingly, removal of aSyn is assumed of having the potential to modify the course of the disease. Both active and passive aSyn targeting immunotherapy were found to modify disease in mice overexpressing human aSyn and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2012-02-22)
More Articles from Vaccine Weekly
- Physiology
University of Tubingen Reports Research in Physiology - Vaccines
University of Tennessee College of Medicine Reports Research in Vaccines - Staphylococcus aureus
University of Reading Reports Research in Staphylococcus aureus - Salmonella
University of Birmingham Details Research in Salmonella - Influenza Vaccines
University of Maryland School of Medicine Details Research in Influenza Vaccines - Vaccines
The Valley Hospital in Ridgewood, NJ, Now Participating in a Clinical Trial Studying Personalized Vaccine for Treating a Common Form of Brain Tumor - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
